18 hours China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drugInvesting.com X
2 days Biotech: 3 Reasons The Recent Selloff Is A Buying Opportunity For XBI (Upgrade)Seeking Alpha X
2 days The Zacks Analyst Blog Highlights SPDR S&P Biotech ETF, SPDR S&P Semiconductor ETF, First Trust Indxx Aerospace & Defense ETF, First Trust NASDAQ-100-Technology Sector Index Fund and iShares U.S. Digital Infrastructure and Real Estate ETFZacks X
3 days Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climateMarketWatch X
7 days Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study DataZacks X
1 week Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a MonthThe Motley Fool X
1 week This biotech’s stock could double if its treatment for major depressive disorder succeeds, says MizuhoMarketWatch X
1 week Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation OpportunityThe Motley Fool X
1 week Top Biotech Neurogene Crashes 44%, Wiping Out Its Sprint On A $200 Million DealInvestor's Business Daily X
1 week Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in HealthcareInsider Monkey X
2 weeks 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or MoreThe Motley Fool X
2 weeks Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide marginMarketWatch X
2 weeks Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidanceMarketWatch X
2 weeks Biotech Stocks Edge Higher. Could Trump 2.0 Mean More Innovation, Dealmaking?Investor's Business Daily X
2 weeks Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?The Motley Fool X
Market Insider